These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7171849)

  • 1. Effect of styrene on dopamine receptors.
    Agrawal AK; Srivastava SP; Seth PK
    Bull Environ Contam Toxicol; 1982 Oct; 29(4):400-3. PubMed ID: 7171849
    [No Abstract]   [Full Text] [Related]  

  • 2. Aging brain and dopamine receptors: abnormal regulation by CCK-8 of 3H-spiperone labeled dopamine receptors in striatal membranes.
    Agnati LF; Fuxe K; Battistini N; Benfenati F
    Acta Physiol Scand; 1984 Mar; 120(3):465-7. PubMed ID: 6331074
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of styrene oxide on dopamine receptors in rats.
    Zaidi NF; Agrawal AK; Srivastava SP; Seth PK
    Bull Environ Contam Toxicol; 1985 Nov; 35(5):602-7. PubMed ID: 4074923
    [No Abstract]   [Full Text] [Related]  

  • 4. Guanine nucleotides distinguish between two dopamine receptors.
    Creese I; Usdin T; Snyder SH
    Nature; 1979 Apr; 278(5704):577-8. PubMed ID: 431724
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of (3H)-terguride and (3H)-spiperone binding to dopamine receptors in the rat striatum.
    Valchár M; Dobrovský K; Krejcí I; Dlabac A
    Act Nerv Super (Praha); 1989 Apr; 31(1):77-9. PubMed ID: 2675526
    [No Abstract]   [Full Text] [Related]  

  • 6. Increase in in vivo (3H) spiperone binding in the rat hippocampal formation and striatum after repeated treatment with haloperidol.
    Bischoff S
    Experientia; 1981; 37(9):1008-9. PubMed ID: 7297644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine receptor binding is increased in diabetic rats.
    Lozovsky D; Saller CF; Kopin IJ
    Science; 1981 Nov; 214(4524):1031-3. PubMed ID: 6458088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumors producing chronic hyperprolactinemia do not alter [3H]spiperone binding and dopamine turnover in the corpus striatum of the female rat.
    Cronin MJ; Reches A; MacLeod RM; Login IS
    Eur J Pharmacol; 1983 Jul; 91(2-3):229-34. PubMed ID: 6617744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions of a partial ergoline with dopamine receptors in vivo and in vitro.
    Fuxe K; Goldstein M; Agnati LF; Köhler C; Lew JY; Okada K
    Acta Physiol Scand; 1983 Feb; 117(2):303-5. PubMed ID: 6869037
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of striatal dopamine release by the selective D-2 dopamine receptor agonist N-0437 is blocked by quinine.
    Cass WA; Zahniser NR
    Synapse; 1990; 5(4):336-7. PubMed ID: 2141733
    [No Abstract]   [Full Text] [Related]  

  • 11. Interaction of flunarizine with dopamine D2 and D1 receptors.
    Ambrosio C; Stefanini E
    Eur J Pharmacol; 1991 May; 197(2-3):221-3. PubMed ID: 1833208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Striatal dopamine receptor function in morphine-tolerant dependent rats: influence of hypothalamic peptides.
    Bhargava HN
    NIDA Res Monogr; 1984 Mar; 49():320-6. PubMed ID: 6148693
    [No Abstract]   [Full Text] [Related]  

  • 13. Binding characteristics of the dopamine agonist/antagonist [3H]terguride (transdihydrolisuride) in the rat striatum.
    Valchár M; Vrsecká M; Krejcí I; Dlabac A
    Eur J Pharmacol; 1987 Apr; 136(1):97-101. PubMed ID: 3297739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of kainic acid on striatal dopamine receptors.
    Weinreich P; Seeman P
    Brain Res; 1980 Oct; 198(2):491-6. PubMed ID: 7407614
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of guanine nucleotides on striatal dopamine receptors.
    Zahniser NR; Molinoff PB
    Nature; 1978 Oct; 275(5679):453-5. PubMed ID: 692725
    [No Abstract]   [Full Text] [Related]  

  • 16. Early supersensitive changes in [3H] spiroperidol binding in the isolated striatum.
    Csernansky JG; Friedhoff AJ; Bonnet KA
    Biochem Biophys Res Commun; 1982 Mar; 105(1):117-20. PubMed ID: 6124243
    [No Abstract]   [Full Text] [Related]  

  • 17. Differentiation by ascorbic acid of dopamine agonist and antagonist binding sites in striatum.
    Kayaalp SO; Neff NH
    Life Sci; 1980 Jun; 26(22):1837-41. PubMed ID: 7401904
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of lesion of cortical dopamine terminals on subcortical dopamine receptors in rats.
    Pycock CJ; Kerwin RW; Carter CJ
    Nature; 1980 Jul; 286(5768):74-6. PubMed ID: 7393327
    [No Abstract]   [Full Text] [Related]  

  • 19. During one year's neuroleptic treatment in rats striatal dopamine receptor blockade decreases but serum prolactin levels remain elevated.
    Dyer RG; Murugaiah K; Theodorou A; Clow A; Jenner P; Marsden CD
    Life Sci; 1981 Jan; 28(2):167-74. PubMed ID: 6114373
    [No Abstract]   [Full Text] [Related]  

  • 20. Interaction between GABA agonists and the cholinergic muscarinic system in rat corpus striatum.
    Ferkany JW; Enna SJ
    Life Sci; 1980 Jul; 27(2):143-9. PubMed ID: 7401929
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.